DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Deibert P, Lazaro A, Stankovic Z, Schaffner D, Rössle M, Kreisel W.
Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: a case report with 8 years follow-up.
World J Gastroenterol 2018;
24 (03) 438-444
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.